在prolyl oligopeptidase中抑制剂结合的结构可视化
Katarzyna Walczewska-Szewc1, Jakub Rydzewski1
1Institute of Physics, Faculty of Physics, Astronomy and Informatics, Nicolaus Copernicus University in Toruń, ul. Grudziądzka 5, 87-100 Toruń, Poland.
Biophysics reviews
|August 26, 2024
概括
了解药物分子如何与诸如prolyl oligopeptidase (PREP) 等蛋白质结合,是开发新疗法的关键. 这项研究可视化了抑制剂的微小变化如何影响PREP.
科学领域:
- 生物物理学的生物物理.
- 计算化学的计算化学
- 神经科学是一个神经科学.
背景情况:
- 蛋白质 - 连接体相互作用对于药物开发至关重要,但对其进行研究具有挑战性.
- 分子动力学 (MD) 模拟通常需要对罕见事件 (如带结合) 进行增强采样.
- 普罗利寡酶 (PREP) 与神经退行性疾病和蛋白质聚合有关.
研究的目的:
- 为了研究PREP中的多种连接体结合途径.
- 了解微妙的抑制剂修改如何影响PREP动态和结合.
- 为治疗向提供对连接体运输机制的视觉洞察.
主要方法:
- 增强采样分子动力学 (MD) 模拟.
- 通过蛋白质过渡道进行连接物通路的视觉分析.
- 蛋白质-配体相互作用的计算建模.
主要成果:
- 在PREP中的联结路径对抑制剂结构的微小变化敏感.
- 增强采样MD成功可视化了复杂的配体运输路径.
- 该研究确定了受抑制性质影响的独特结合机制.
结论:
- 可视化连接体结合通路对于理解PREP在神经退行过程中的作用至关重要.
- 微妙的抑制剂修改可以显著改变治疗潜力.
- 这项工作有助于设计更有效的PREP抑制剂用于神经退行性疾病.
相关概念视频
Enzymes
81.2K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Enzyme Inhibition
78.1K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.1K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K


